## Ichor Holdings (NASDAQ: ICHR) — Filings/Disclosures–Based Deep Dive on the Guide-Driven Re-Rating ### Executive takeaway Ichor’s latest disclosure package is less about a one-quarter beat and more about **an inflection narrative built on (i) a demand turn, (ii) self-help gross margin initiatives, and (iii) the “kitchen-sink” recognition of inventory/footprint charges that can mechanically clean up forward margins**—all while the company remains constrained by **credit agreement leverage/fixed-charge covenants** that implicitly reward EBITDA stabilization. ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["Financial Covenants"](0001652535-25-000064|1) --- ## 1) What the company actually guided (and why it mattered) ### Q1 2026 outlook (company-issued) Management guided **Q1 2026 revenue to $240M–$260M (midpoint $250M)**, with **GAAP diluted EPS of $(0.10) to $0.02** and **non-GAAP diluted EPS of $0.08 to $0.16**. ["Revenue $240 million"](0001652535-26-000008|1) ["GAAP diluted EPS"](0001652535-26-000008|1) ["Non-GAAP diluted EPS"](0001652535-26-000008|1) **Hidden alpha angle:** the guide isn’t just “above Street”; it implicitly signals (a) **volume recovery from a trough quarter** and (b) **earnings torque** even with still-depressed GAAP profitability (the midpoint is still a GAAP loss). ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["GAAP diluted EPS"](0001652535-26-000008|1) ### The key “beat” was not GAAP profit—watch the framing The disclosures highlight **Q4 2025 non-GAAP diluted EPS of $0.01** (vs. GAAP loss), which is what enables the “surprise profit” narrative. ["non-GAAP diluted EPS was $0.01"](0001652535-26-000008|1) ["Earnings (loss) per share of $(0.46)"](0001652535-26-000008|1) --- ## 2) The “step-function” embedded in the revenue guide (quantified) Q4 2025 revenue was **$223.6M**. ["Revenue was $223.6 million"](0001652535-26-000008|1) At the **Q1 midpoint ($250M)**, sequential growth is **~11.8% Q/Q (computed)** = (250.0 − 223.6) / 223.6. ["Revenue $250 million"](0001652535-26-000008|1) ["Revenue was $223.6 million"](0001652535-26-000008|1) **Why this can be “invisible alpha”:** a large part of Ichor’s P&L pressure has been **absorption/underutilization + discrete restructuring-related charges**; an ~12% sequential revenue step can create **gross margin and operating leverage** that looks disproportionate versus the revenue delta—especially once “cleansing” charges roll off (see §3). ["gross margin improvement strategies"](0001652535-26-000008|1) ["Restructuring plan costs"](0001652535-26-000008|1) --- ## 3) The margin story is partly operational, partly accounting: charges already taken ### Q4 profitability snapshot (GAAP vs non-GAAP) - **Q4 2025 GAAP gross margin:** 9.4% ["Gross margin of 9.4%"](0001652535-26-000008|1) - **Q4 2025 non-GAAP gross margin:** 11.7% ["Non-GAAP gross margin 11.7"](0001652535-26-000008|1) - **Q4 2025 GAAP operating margin:** (6.2)% ["Operating margin | (6.2)"](0001652535-26-000008|1) - **Q4 2025 non-GAAP operating margin:** 1.2% ["Operating margin | 1.2"](0001652535-26-000008|1) ### The “clean-up” items: inventory impairment + footprint exits Management’s non-GAAP reconciliations explicitly call out **restructuring plan costs** that include **inventory impairment** and other exit-related costs. ["inventory impairment costs of $3.1 million"](0001652535-26-000008|1) ["inventory impairment costs of $19.8 million"](0001652535-26-000008|1) ["exit from our Scotland and Korea operations"](0001652535-26-000008|1) In the prior quarter’s 10-Q, the company disclosed a **Consolidation Restructuring Plan** with **$16.7M inventory impairment recognized in Q3 2025**, plus expected additional fixed asset and ROU impairment charges and a timeline through **end of 2026**. ["inventory impairment costs under the Plan are $16.7 million"](0001652535-25-000078|0) ["additional $4.2 million"](0001652535-25-000078|0) ["substantially complete by the end of 2026"](0001652535-25-000078|0) **Hidden alpha angle:** the stock can “look expensive” immediately after a guide-driven spike, but **the earnings power may be understated** if the market treats these charges as recurring. The filings show these are tied to discrete plans/exits with an explicit completion horizon, which supports a multi-quarter normalization view if demand holds. ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["exit from our Scotland and Korea operations"](0001652535-26-000008|1) --- ## 4) Cash flow and working capital: the underappreciated bridge to sustainability ### Q4 2025 cash and operating cash flow Ichor ended Q4 2025 with **$98.3M cash** and generated **$9.2M operating cash flow** in the quarter, with narrative attribution to non-cash charges and working capital movements. ["cash and cash equivalents of $98.3 million"](0001652535-26-000008|1) ["net cash provided by operating activities of $9.2 million"](0001652535-26-000008|1) The working-capital release is visible: the company cites **accounts receivable down $13.9M** and **inventory down $6.8M** in Q4 (offset by AP and accrual changes). ["decrease in accounts receivable of $13.9 million"](0001652535-26-000008|1) ["decrease in inventory of $6.8 million"](0001652535-26-000008|1) **Hidden alpha angle:** for a cyclical semicap supply chain name, **the market often over-weights “EPS optics” and under-weights early working-capital stabilization**. If Q1 demand is real, you want to see this evolve from one-time working capital release into *structural* cash conversion (less inventory impairment, more turns). ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Impairment of inventory"](0001652535-26-000008|1) ### Free cash flow context (don’t ignore this) For FY2025, the company reported **operating cash flow $29.9M** and **capex $36.2M**, yielding **free cash flow of $(6.3)M**. ["cash provided by operating activities of $29.9 million"](0001652535-26-000008|1) ["capital expenditures of $36.2 million"](0001652535-26-000008|1) ["Free cash flow | (6,283)"](0001652535-26-000008|1) **Implication:** the “ride the guide” case improves materially if the revenue inflection converts into **positive FCF after capex** (not just non-GAAP EPS). ["Free cash flow"](0001652535-26-000008|1) --- ## 5) Balance sheet & credit agreement: the constraint that creates (and limits) hidden alpha ### Net debt is low—but covenants still matter At Q4 2025, Ichor reported: - **Current portion of long-term debt:** $6.25M ["Current portion of long-term debt | 6,250"](0001652535-26-000008|1) - **Long-term debt (non-current):** $117.278M ["Long-term debt, less current portion, net | 117,278"](0001652535-26-000008|1) - **Cash:** $98.29M ["Cash and cash equivalents | 98,290"](0001652535-26-000008|1) So **net debt ≈ $25.24M (computed)** = (6.25 + 117.278) − 98.29. ["Current portion of long-term debt | 6,250"](0001652535-26-000008|1) ["Long-term debt, less current portion, net | 117,278"](0001652535-26-000008|1) ["Cash and cash equivalents | 98,290"](0001652535-26-000008|1) **Hidden alpha angle:** even with modest net debt, the *credit agreement* can act like an “invisible hand” on capital allocation and risk appetite—particularly around acquisitions, buybacks, and flexibility through downturns. ### Key covenant framework (as disclosed in the amended/restated credit agreement) The September 26, 2025 amended and restated credit agreement includes: - **Max Consolidated Leverage Ratio:** **3.25:1.00**, with a temporary step-up to **3.75:1.00** after a qualifying acquisition. ["greater than 3.25:1.00"](0001652535-25-000064|1) ["increased to 3.75:1.00"](0001652535-25-000064|1) - **Min Consolidated Fixed Charge Coverage Ratio:** **1.25:1.00**. ["less than 1.25:1.00"](0001652535-25-000064|1) - **Restricted payments flex:** additional restricted payments permitted only if **pro forma leverage ≤ 2.00:1.00** (among other conditions). ["does not exceed 2.00 to 1.00"](0001652535-25-000064|1) - **Equity cure mechanism** exists for covenant breaches (with limitations and required use to prepay term loans). ["Equity Cure"](0001652535-25-000064|1) **How this creates tradeable signal:** if Q1–Q2 execution improves EBITDA, the company can **move down its leverage grid** and regain optionality; if demand is weaker than implied, covenant headroom becomes a *non-obvious* overhang even before liquidity is an issue. ["Financial Covenants"](0001652535-25-000064|1) --- ## 6) “Invisible” accounting lever: depreciation life change already boosting reported results In the Q3 2025 10-Q, Ichor disclosed a **change in accounting estimate** extending useful lives of CNC machinery from **7 to 10 years**, reducing cost-of-sales depreciation and lowering losses (quantified by management). ["useful life ... increased from seven to ten years"](0001652535-25-000078|0) ["decrease to depreciation expense ... $1.0 million"](0001652535-25-000078|0) ["reduced Operating loss and Net loss"](0001652535-25-000078|0) **Hidden alpha angle (two-sided):** - **Bull case:** if volumes recover, you get *real* operating leverage on top of a lower depreciation run-rate. ["expect this upward trend"](0001652535-26-000008|1) - **Bear case:** some “margin improvement” may be partially **optical** from depreciation assumptions and non-GAAP add-backs—so you want evidence of *true* manufacturing efficiency/price/cost actions. ["change in estimate reduced Operating loss"](0001652535-25-000078|0) --- ## 7) What the market did today (context only) ICHR traded up sharply on the day, with a last price of **$45.46** and **+33.27%** change in the quote snapshot used here. ["Current Price | 45.46"](i9k82c) ["Change % | 33.2747"](i9k82c) Street price target averages (supporting data) show **last-month average ~$34.71**. ["Last Month Avg Price Target | 34.71"](9rpr08) **Interpretation:** the move appears to have **pulled forward** a sizable portion of the re-rating the sell-side had in targets, increasing the odds that near-term returns hinge on **follow-through beats** rather than just “better guide optics.” ["Last Month Avg Price Target"](9rpr08) ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) --- ## 8) Ride the guide or fade the pop? — A filings-grounded decision framework ### The “ride” setup (when it works) 1) **The guide implies a real demand turn, not a one-quarter restock.** Management explicitly frames Q1 as upward momentum from Q4 trough and expects trend into 2H. ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["continue into the second half"](0001652535-26-000008|1) 2) **Charges have already been recognized, enabling cleaner forward comparisons.** Inventory impairment and footprint exits are already flowing through reconciliations and restructuring disclosures. ["inventory impairment costs"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) 3) **Cash flow turns structurally positive**, not just one quarter of working-capital release. ["net cash provided by operating activities of $9.2 million"](0001652535-26-000008|1) ["decrease in inventory"](0001652535-26-000008|1) ### The “fade” setup (when it works) 1) **GAAP profitability is still weak** (midpoint GAAP EPS is still negative for Q1), leaving less cushion if demand wobbles. ["GAAP diluted EPS | $(0.04)"](0001652535-26-000008|1) 2) **Non-GAAP profitability relies on add-backs that have been meaningful**, especially restructuring and other items. ["Restructuring plan costs"](0001652535-26-000008|1) 3) **Credit agreement covenants amplify downside** if EBITDA doesn’t inflect as expected—because flexibility (including acquisitions/returns of capital) is conditional and covenant remediation can require equity cure / term-loan prepay. ["Financial Covenants"](0001652535-25-000064|1) ["Equity Cure"](0001652535-25-000064|1) --- ## Bottom line - If you believe the disclosure language about **Q4 trough → Q1 momentum → 2H continuation** is directionally correct, the hidden alpha is that **Ichor has already expensed a meaningful portion of the “messy” restructuring/inventory actions**, setting up a cleaner operating leverage ramp if revenue continues to climb. ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["inventory impairment costs"](0001652535-26-000008|1) - If you think the guide is more “one-quarter snapback,” the risk is that the stock’s **gap-up to ~$45** (above recent average targets in the snapshot) leaves you owning a name where **GAAP earnings are still fragile** and covenant structure can re-emerge as a narrative drag in any stumble. ["Current Price | 45.46"](i9k82c) ["Last Month Avg Price Target | 34.71"](9rpr08) ["GAAP diluted EPS"](0001652535-26-000008|1) If you want, I can convert this into a one-page “trade plan” with explicit bull/base/bear checkpoints tied to *specific* line items to monitor in the next 10-Q (gross margin bridge, restructuring spend roll-forward, inventory turns, and covenant ratio disclosures). ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["Financial Covenants"](0001652535-25-000064|1)

## Ichor Holdings (NASDAQ: ICHR) — Filings/Disclosures–Based Deep Dive on the Guide-Driven Re-Rating ### Executive takeaway Ichor’s latest disclosure package is less about a one-quarter beat and more about **an inflection narrative built on (i) a demand turn, (ii) self-help gross margin initiatives, and (iii) the “kitchen-sink” recognition of inventory/footprint charges that can mechanically clean up forward margins**—all while the company remains constrained by **credit agreement leverage/fixed-charge covenants** that implicitly reward EBITDA stabilization. ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["Financial Covenants"](0001652535-25-000064|1) --- ## 1) What the company actually guided (and why it mattered) ### Q1 2026 outlook (company-issued) Management guided **Q1 2026 revenue to $240M–$260M (midpoint $250M)**, with **GAAP diluted EPS of $(0.10) to $0.02** and **non-GAAP diluted EPS of $0.08 to $0.16**. ["Revenue $240 million"](0001652535-26-000008|1) ["GAAP diluted EPS"](0001652535-26-000008|1) ["Non-GAAP diluted EPS"](0001652535-26-000008|1) **Hidden alpha angle:** the guide isn’t just “above Street”; it implicitly signals (a) **volume recovery from a trough quarter** and (b) **earnings torque** even with still-depressed GAAP profitability (the midpoint is still a GAAP loss). ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["GAAP diluted EPS"](0001652535-26-000008|1) ### The key “beat” was not GAAP profit—watch the framing The disclosures highlight **Q4 2025 non-GAAP diluted EPS of $0.01** (vs. GAAP loss), which is what enables the “surprise profit” narrative. ["non-GAAP diluted EPS was $0.01"](0001652535-26-000008|1) ["Earnings (loss) per share of $(0.46)"](0001652535-26-000008|1) --- ## 2) The “step-function” embedded in the revenue guide (quantified) Q4 2025 revenue was **$223.6M**. ["Revenue was $223.6 million"](0001652535-26-000008|1) At the **Q1 midpoint ($250M)**, sequential growth is **~11.8% Q/Q (computed)** = (250.0 − 223.6) / 223.6. ["Revenue $250 million"](0001652535-26-000008|1) ["Revenue was $223.6 million"](0001652535-26-000008|1) **Why this can be “invisible alpha”:** a large part of Ichor’s P&L pressure has been **absorption/underutilization + discrete restructuring-related charges**; an ~12% sequential revenue step can create **gross margin and operating leverage** that looks disproportionate versus the revenue delta—especially once “cleansing” charges roll off (see §3). ["gross margin improvement strategies"](0001652535-26-000008|1) ["Restructuring plan costs"](0001652535-26-000008|1) --- ## 3) The margin story is partly operational, partly accounting: charges already taken ### Q4 profitability snapshot (GAAP vs non-GAAP) - **Q4 2025 GAAP gross margin:** 9.4% ["Gross margin of 9.4%"](0001652535-26-000008|1) - **Q4 2025 non-GAAP gross margin:** 11.7% ["Non-GAAP gross margin 11.7"](0001652535-26-000008|1) - **Q4 2025 GAAP operating margin:** (6.2)% ["Operating margin | (6.2)"](0001652535-26-000008|1) - **Q4 2025 non-GAAP operating margin:** 1.2% ["Operating margin | 1.2"](0001652535-26-000008|1) ### The “clean-up” items: inventory impairment + footprint exits Management’s non-GAAP reconciliations explicitly call out **restructuring plan costs** that include **inventory impairment** and other exit-related costs. ["inventory impairment costs of $3.1 million"](0001652535-26-000008|1) ["inventory impairment costs of $19.8 million"](0001652535-26-000008|1) ["exit from our Scotland and Korea operations"](0001652535-26-000008|1) In the prior quarter’s 10-Q, the company disclosed a **Consolidation Restructuring Plan** with **$16.7M inventory impairment recognized in Q3 2025**, plus expected additional fixed asset and ROU impairment charges and a timeline through **end of 2026**. ["inventory impairment costs under the Plan are $16.7 million"](0001652535-25-000078|0) ["additional $4.2 million"](0001652535-25-000078|0) ["substantially complete by the end of 2026"](0001652535-25-000078|0) **Hidden alpha angle:** the stock can “look expensive” immediately after a guide-driven spike, but **the earnings power may be understated** if the market treats these charges as recurring. The filings show these are tied to discrete plans/exits with an explicit completion horizon, which supports a multi-quarter normalization view if demand holds. ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["exit from our Scotland and Korea operations"](0001652535-26-000008|1) --- ## 4) Cash flow and working capital: the underappreciated bridge to sustainability ### Q4 2025 cash and operating cash flow Ichor ended Q4 2025 with **$98.3M cash** and generated **$9.2M operating cash flow** in the quarter, with narrative attribution to non-cash charges and working capital movements. ["cash and cash equivalents of $98.3 million"](0001652535-26-000008|1) ["net cash provided by operating activities of $9.2 million"](0001652535-26-000008|1) The working-capital release is visible: the company cites **accounts receivable down $13.9M** and **inventory down $6.8M** in Q4 (offset by AP and accrual changes). ["decrease in accounts receivable of $13.9 million"](0001652535-26-000008|1) ["decrease in inventory of $6.8 million"](0001652535-26-000008|1) **Hidden alpha angle:** for a cyclical semicap supply chain name, **the market often over-weights “EPS optics” and under-weights early working-capital stabilization**. If Q1 demand is real, you want to see this evolve from one-time working capital release into *structural* cash conversion (less inventory impairment, more turns). ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Impairment of inventory"](0001652535-26-000008|1) ### Free cash flow context (don’t ignore this) For FY2025, the company reported **operating cash flow $29.9M** and **capex $36.2M**, yielding **free cash flow of $(6.3)M**. ["cash provided by operating activities of $29.9 million"](0001652535-26-000008|1) ["capital expenditures of $36.2 million"](0001652535-26-000008|1) ["Free cash flow | (6,283)"](0001652535-26-000008|1) **Implication:** the “ride the guide” case improves materially if the revenue inflection converts into **positive FCF after capex** (not just non-GAAP EPS). ["Free cash flow"](0001652535-26-000008|1) --- ## 5) Balance sheet & credit agreement: the constraint that creates (and limits) hidden alpha ### Net debt is low—but covenants still matter At Q4 2025, Ichor reported: - **Current portion of long-term debt:** $6.25M ["Current portion of long-term debt | 6,250"](0001652535-26-000008|1) - **Long-term debt (non-current):** $117.278M ["Long-term debt, less current portion, net | 117,278"](0001652535-26-000008|1) - **Cash:** $98.29M ["Cash and cash equivalents | 98,290"](0001652535-26-000008|1) So **net debt ≈ $25.24M (computed)** = (6.25 + 117.278) − 98.29. ["Current portion of long-term debt | 6,250"](0001652535-26-000008|1) ["Long-term debt, less current portion, net | 117,278"](0001652535-26-000008|1) ["Cash and cash equivalents | 98,290"](0001652535-26-000008|1) **Hidden alpha angle:** even with modest net debt, the *credit agreement* can act like an “invisible hand” on capital allocation and risk appetite—particularly around acquisitions, buybacks, and flexibility through downturns. ### Key covenant framework (as disclosed in the amended/restated credit agreement) The September 26, 2025 amended and restated credit agreement includes: - **Max Consolidated Leverage Ratio:** **3.25:1.00**, with a temporary step-up to **3.75:1.00** after a qualifying acquisition. ["greater than 3.25:1.00"](0001652535-25-000064|1) ["increased to 3.75:1.00"](0001652535-25-000064|1) - **Min Consolidated Fixed Charge Coverage Ratio:** **1.25:1.00**. ["less than 1.25:1.00"](0001652535-25-000064|1) - **Restricted payments flex:** additional restricted payments permitted only if **pro forma leverage ≤ 2.00:1.00** (among other conditions). ["does not exceed 2.00 to 1.00"](0001652535-25-000064|1) - **Equity cure mechanism** exists for covenant breaches (with limitations and required use to prepay term loans). ["Equity Cure"](0001652535-25-000064|1) **How this creates tradeable signal:** if Q1–Q2 execution improves EBITDA, the company can **move down its leverage grid** and regain optionality; if demand is weaker than implied, covenant headroom becomes a *non-obvious* overhang even before liquidity is an issue. ["Financial Covenants"](0001652535-25-000064|1) --- ## 6) “Invisible” accounting lever: depreciation life change already boosting reported results In the Q3 2025 10-Q, Ichor disclosed a **change in accounting estimate** extending useful lives of CNC machinery from **7 to 10 years**, reducing cost-of-sales depreciation and lowering losses (quantified by management). ["useful life ... increased from seven to ten years"](0001652535-25-000078|0) ["decrease to depreciation expense ... $1.0 million"](0001652535-25-000078|0) ["reduced Operating loss and Net loss"](0001652535-25-000078|0) **Hidden alpha angle (two-sided):** - **Bull case:** if volumes recover, you get *real* operating leverage on top of a lower depreciation run-rate. ["expect this upward trend"](0001652535-26-000008|1) - **Bear case:** some “margin improvement” may be partially **optical** from depreciation assumptions and non-GAAP add-backs—so you want evidence of *true* manufacturing efficiency/price/cost actions. ["change in estimate reduced Operating loss"](0001652535-25-000078|0) --- ## 7) What the market did today (context only) ICHR traded up sharply on the day, with a last price of **$45.46** and **+33.27%** change in the quote snapshot used here. ["Current Price | 45.46"](i9k82c) ["Change % | 33.2747"](i9k82c) Street price target averages (supporting data) show **last-month average ~$34.71**. ["Last Month Avg Price Target | 34.71"](9rpr08) **Interpretation:** the move appears to have **pulled forward** a sizable portion of the re-rating the sell-side had in targets, increasing the odds that near-term returns hinge on **follow-through beats** rather than just “better guide optics.” ["Last Month Avg Price Target"](9rpr08) ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) --- ## 8) Ride the guide or fade the pop? — A filings-grounded decision framework ### The “ride” setup (when it works) 1) **The guide implies a real demand turn, not a one-quarter restock.** Management explicitly frames Q1 as upward momentum from Q4 trough and expects trend into 2H. ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["continue into the second half"](0001652535-26-000008|1) 2) **Charges have already been recognized, enabling cleaner forward comparisons.** Inventory impairment and footprint exits are already flowing through reconciliations and restructuring disclosures. ["inventory impairment costs"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) 3) **Cash flow turns structurally positive**, not just one quarter of working-capital release. ["net cash provided by operating activities of $9.2 million"](0001652535-26-000008|1) ["decrease in inventory"](0001652535-26-000008|1) ### The “fade” setup (when it works) 1) **GAAP profitability is still weak** (midpoint GAAP EPS is still negative for Q1), leaving less cushion if demand wobbles. ["GAAP diluted EPS | $(0.04)"](0001652535-26-000008|1) 2) **Non-GAAP profitability relies on add-backs that have been meaningful**, especially restructuring and other items. ["Restructuring plan costs"](0001652535-26-000008|1) 3) **Credit agreement covenants amplify downside** if EBITDA doesn’t inflect as expected—because flexibility (including acquisitions/returns of capital) is conditional and covenant remediation can require equity cure / term-loan prepay. ["Financial Covenants"](0001652535-25-000064|1) ["Equity Cure"](0001652535-25-000064|1) --- ## Bottom line - If you believe the disclosure language about **Q4 trough → Q1 momentum → 2H continuation** is directionally correct, the hidden alpha is that **Ichor has already expensed a meaningful portion of the “messy” restructuring/inventory actions**, setting up a cleaner operating leverage ramp if revenue continues to climb. ["upward momentum from Q4’s trough"](0001652535-26-000008|1) ["inventory impairment costs"](0001652535-26-000008|1) - If you think the guide is more “one-quarter snapback,” the risk is that the stock’s **gap-up to ~$45** (above recent average targets in the snapshot) leaves you owning a name where **GAAP earnings are still fragile** and covenant structure can re-emerge as a narrative drag in any stumble. ["Current Price | 45.46"](i9k82c) ["Last Month Avg Price Target | 34.71"](9rpr08) ["GAAP diluted EPS"](0001652535-26-000008|1) If you want, I can convert this into a one-page “trade plan” with explicit bull/base/bear checkpoints tied to *specific* line items to monitor in the next 10-Q (gross margin bridge, restructuring spend roll-forward, inventory turns, and covenant ratio disclosures). ["First Quarter 2026 Financial Outlook"](0001652535-26-000008|1) ["Consolidation Restructuring Plan"](0001652535-25-000078|0) ["Financial Covenants"](0001652535-25-000064|1)